Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 14Colorectal Neoplasms 11Rectal Neoplasms 6Stomach Neoplasms 5Colonic Neoplasms 4Ovarian Neoplasms 3Neoplasm Metastasis 3Esophageal Neoplasms 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Pancreatic Adenocarcinoma 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Borderline Resectable Pancreatic Adenocarcinoma 2Appendiceal Neoplasms 2Uterine Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocytosis 1Somatostatinoma 1Sinonasal undifferentiated carcinoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Paranasal Sinus Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1

Interventions

Radiotherapy 2Docetaxel 2Cisplatin 2Carboplatin 2toripalimab 1dehydroftorafur 1Radiotherapy, Intensity-Modulated 1Radiation 1Protons 1Platinum 1Fluorouracil 1Chemoradiotherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sinonasal undifferentiated carcinoma × dehydroftorafur × Clear all
NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡